Solid Floors, Slipping Shares

James Halstead PLC — UK-based manufacturer and international distributor of floor coverings, headquartered in Manchester. All figures in pounds sterling.

James Halstead PLC (ticker JHD) is a UK-based manufacturer and international distributor of floor coverings, headquartered in Manchester (Radcliffe / Bury). They make high-quality, sustainable vinyl flooring solutions under their core brand Polyflor, alongside some residential floor coverings. In Germany they operate a company called Objectflor, which produces very similar products.

On a commercial basis they produce homogeneous flooring (full-length, seamless) and heterogeneous flooring (which has lines and design within it), as well as safety flooring and luxury vinyl flooring, including parquet-style vinyl. Their flooring is used across leisure and hospitality, retail, health and care, schooling, and industrial complexes. In the home they do luxury vinyl tiles, sheet vinyl tiling, inlay accessories, interlocking LVT, and fake-parquet flooring.

By geography, the UK is the largest market at around 44.25% of turnover. The company reports four geographic segments: United Kingdom; Europe & Scandinavia; Australasia & Asia; and Rest of the World. Roughly half of group sales are linked to the healthcare and education sectors, which are less sensitive to economic downturns than residential construction.

Revenue by region and brand

The flagship Polyflor brand is the core engine — homogeneous vinyl (high-traffic), heterogeneous vinyl (design flexibility), safety/slip-resistant flooring, and luxury vinyl tiles (the Expona range). Riverside sells exclusively through Polyflor. The principal area of recent sales shortfall has been luxury vinyl tiles, which cross into the more discretionary domestic consumer market. ("LFL" is like-for-like — growth excluding acquisitions and disposals; "local ccy" is local currency.)

This is a relatively small company, with a market capitalisation of around £531.3m. It offers a very meaty 6.9% dividend. The revenue picture has been historically lacklustre and is now negative across the last two years — since 2020 they have essentially achieved flat sales.

Six-year financial history

They saw sales of £239m in 2020, rising to £304m in 2023, then back down to £275m (2024) and £262m (2025). But despite this turnover movement, operating profit has been very flat — £53m last year, which was slightly surprising given the fluctuations in turnover. The gross margin hit 44.5% last year, historically reasonably high, on a general upswing from the 38.9% low in 2022. They are achieving a surprisingly high profit on turnover of 15.5%, which is good for the manufacturing area they are in — definitely not terrible.

If you look at average earnings per share over the five-year period, it has been around 3.4% growth on average — but in the last two years it has been negative, and I don't really know why that is the case. Net borrowing (in the sense of net cash) sits at a positive £64m; it has always been at healthy levels, briefly dipping to £46m in 2022. The balance sheet is strong with a substantial net cash position.

The most recent trading update was the interim results for the six months ended 31 December 2025, published on 31 March 2026:

H1 FY2026 interims (six months to 31 December 2025)

UK sales softened just before 31 December 2025 but picked up in the first two months of 2026. Middle East issues are causing headwinds in raw material, energy and transport costs (affecting competitors at least as badly). A record interim dividend continues a 49+ year record of dividend increases.

I'm not going to investigate this company much further because nothing much seems to be happening with it financially. They have a very high yield at 6.9%, and given that their profitability has been unaffected recently despite the swings in turnover, it sounds reasonably legitimate to assume they can continue this forward. I don't think they are about to cut dividends or anything along those lines — but I think it's also unlikely they're going to see a sudden jump in profitability.

If you want something good for parking your cash, this might be the kind of thing — but you won't be seeing strong growth. Over the last two years the share price has dropped from about 200p to the current 127.6p; they are on a long-term slide in share price and share value, which is why the dividend yield is so high. Over the past twelve months they have slipped around 21% in share value. I imagine there is some concern about consumer spending, but I doubt it will affect the company's profitability too much given the historical figures. Very much a company that's not moving anywhere too fast — but nonetheless pulling out profits.

Note: I haven't done much research into this share, just as a warning — hence the research grade of C.

I'm using their last annual reporting figure of 9.7p earnings per share, with a growth rate of 2% — which might be a little generous given the previous two years of negative movements, but over the longer term they seem to be doing fine. I don't think they have a high risk factor, which is why I'm giving them a 16% risk factor. I can't really see any particular catalyst for why growth would do better in the future.

VALUATION SNAPSHOT

This comes up with a value opportunity of −29.5%, so it's still coming up as overvalued in my opinion. Formula and actual valuation both sit at 90.02p against a current price of 127.60p. A solid, cash-generative, high-yielding business — but on these figures, not one to buy at the current price.

• The income case is genuinely strong: A 6.9% yield backed by stable profits, £64m of net cash and a 49+ year record of dividend increases can support the share price regardless of my valuation — income buyers may simply keep collecting.
• Profitability is proven through the cycle: Operating profit has held around £52–54m through both the turnover surge and the decline. If sales merely stabilise, the earnings base is dependable.
• Defensive end-markets: Roughly half of sales are linked to healthcare and education — far less economically sensitive than residential construction. A consumer recovery would lift the discretionary luxury-vinyl-tile line on top of that stable base.
• Early FY2026 signs: UK sales picked up in the first two months of 2026, and cash inflow from operations jumped 45.8% at the interims.
• Takeover appeal: A cash-rich, family-heritage manufacturer on a depressed price and a 13.2x multiple could attract a bidder.